Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José Iñigo Romón Alonso"'
Autor:
Covadonga López del Moral Cuesta, Sandra Guiral Foz, David Gómez Pereda, José Luis Pérez Canga, Marina de Cos Gómez, Jaime Mazón Ruiz, Ana García Santiago, José Iñigo Romón Alonso, Rosalía Valero San Cecilio, Emilio Rodrigo Calabia, David San Segundo Arribas, Marcos López Hoyos, Juan Carlos Ruiz San Millán
Publikováno v:
Biomedicines, Vol 8, Iss 4, p 72 (2020)
Immunosuppression withdrawal after graft failure seems to favor sensitization. A high percentage of calculated panel-reactive antibody (cPRA) and the development of de novo donor specific antibodies (dnDSA) indicate human leukocyte antigen (HLA) sens
Externí odkaz:
https://doaj.org/article/a5829c30c8144acba624f6647f80a409
Autor:
Marcos López-Hoyos, José Iñigo Romón Alonso, Marina De Cos Gomez, Rosalía Valero San Cecilio, David Gómez Pereda, David San Segundo Arribas, Emilio Rodrigo, Juan Carlos Ruiz San Millán, Sandra Guiral, Covadonga López del Moral Cuesta
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Retransplantation is an important option to consider in patients who return to dialysis after graft failure since it reduces mortality. HLA allosensitization hinders retransplantation, and immunosuppression withdrawal after graft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dffb17d369d251cbd2cb0989451fd66
https://doi.org/10.1093/ndt/gfaa142.p1739
https://doi.org/10.1093/ndt/gfaa142.p1739
Autor:
Ana García Santiago, Sandra Guiral Foz, David San Segundo Arribas, Rosalía Valero San Cecilio, Juan Carlos Ruiz San Millán, Emilio Rodrigo Calabia, Covadonga López del Moral Cuesta, Marina de Cos Gómez, David Gómez Pereda, José Luis Pérez Canga, José Iñigo Romón Alonso, Jaime Mazon Ruiz, Marcos López Hoyos
Publikováno v:
Biomedicines
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 72, p 72 (2020)
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 72, p 72 (2020)
Immunosuppression withdrawal after graft failure seems to favor sensitization. A high percentage of calculated panel-reactive antibody (cPRA) and the development of de novo donor specific antibodies (dnDSA) indicate human leukocyte antigen (HLA) sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad0f57298483de7d98dfcacfb6c6810